BCM
Bayesian Capital Management Portfolio holdings
AUM
$633M
1-Year Return
38.33%
This Quarter Return
+1.04%
1 Year Return
+38.33%
3 Year Return
+146.47%
5 Year Return
+216.79%
10 Year Return
–
AUM
$873M
AUM Growth
-$174M
(-17%)
Cap. Flow
-$167M
Cap. Flow
% of AUM
-19.1%
Top 10 Holdings %
Top 10 Hldgs %
17.05%
Holding
1,175
New
428
Increased
111
Reduced
142
Closed
493
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$39.5M |
| 2 |
Tesla
TSLA
|
$20M |
| 3 |
Adobe
ADBE
|
$12.9M |
| 4 |
Ulta Beauty
ULTA
|
$11.4M |
| 5 |
Citigroup
C
|
$9.64M |
Top Sells
| 1 |
General Motors
GM
|
$12.9M |
| 2 |
Micron Technology
MU
|
$11M |
| 3 |
Cisco
CSCO
|
$10.9M |
| 4 |
Dell
DELL
|
$10.6M |
| 5 |
FedEx
FDX
|
$10.1M |
Sector Composition
| 1 | Technology | 25.04% |
| 2 | Consumer Discretionary | 15.17% |
| 3 | Industrials | 10.75% |
| 4 | Healthcare | 9.76% |
| 5 | Financials | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
Dine Brands
DIN
$364M
| $340K | 0.04% |
+9,400
| New | +$340K |
|
477
Globant
GLOB
$2.78B
| $339K | 0.04% |
+1,903
| New | +$339K |
|
478
Toronto Dominion Bank
TD
$127B
| $339K | 0.04% |
+6,164
| New | +$339K |
|
479
Ternium
TX
$6.79B
| $337K | 0.04% |
+8,981
| New | +$337K |
|
480
Surgery Partners
SGRY
$2.89B
| $336K | 0.04% |
+14,130
| New | +$336K |
|
481
CRISPR Therapeutics
CRSP
$4.99B
| $335K | 0.04% |
6,200
-34,800
| -85% | -$1.88M |
|
482
Deutsche Bank
DB
$67.8B
| $335K | 0.04% |
+21,000
| New | +$335K |
|
483
Bentley Systems
BSY
$16.3B
| $335K | 0.04% |
6,777
-26,620
| -80% | -$1.31M |
|
|
SWTX
484
DELISTED
SpringWorks Therapeutics
SWTX
| $332K | 0.04% |
+8,814
| New | +$332K |
|
485
First Solar
FSLR
$22B
| $328K | 0.04% |
1,455
-14,345
| -91% | -$3.23M |
|
486
HealthEquity
HQY
$7.88B
| $328K | 0.04% |
+3,800
| New | +$328K |
|
487
Kemper
KMPR
$3.39B
| $322K | 0.04% |
5,423
-100
| -2% | -$5.93K |
|
488
SoFi Technologies
SOFI
$30.7B
| $321K | 0.04% |
48,602
-197,998
| -80% | -$1.31M |
|
489
JFrog
FROG
$5.84B
| $319K | 0.04% |
8,500
-7,158
| -46% | -$269K |
|
490
Novavax
NVAX
$1.28B
| $319K | 0.04% |
+25,200
| New | +$319K |
|
491
Recursion Pharmaceuticals
RXRX
$2.01B
| $318K | 0.04% |
+42,400
| New | +$318K |
|
492
Fluence Energy
FLNC
$989M
| $317K | 0.04% |
+18,300
| New | +$317K |
|
493
Huntsman Corp
HUN
$1.95B
| $317K | 0.04% |
13,930
-24,900
| -64% | -$567K |
|
494
Primoris Services
PRIM
$6.32B
| $317K | 0.04% |
+6,347
| New | +$317K |
|
495
UGI
UGI
$7.43B
| $316K | 0.04% |
+13,800
| New | +$316K |
|
496
Harmony Biosciences
HRMY
$2.07B
| $314K | 0.04% |
+10,422
| New | +$314K |
|
497
Varonis Systems
VRNS
$6.28B
| $312K | 0.04% |
6,500
-19,900
| -75% | -$955K |
|
498
American Superconductor
AMSC
$2.21B
| $311K | 0.04% |
+13,300
| New | +$311K |
|
|
HES
499
DELISTED
Hess
HES
| $310K | 0.04% |
2,100
-10,602
| -83% | -$1.56M |
|
500
InMode
INMD
$947M
| $309K | 0.04% |
+16,946
| New | +$309K |
|